<div id="readability-page-1">Key Takeaways Abbott Laboratories has agreed to acquire Exact Sciences Corp. in a deal worth $21 billion, paying shareholders $105 per share.Exact Sciences makes a variety of cancer screening tests, including Cologuard, and expects to generate about $3 billion in revenue this year.Many pharmaceutical companies are spending billions to develop scree...</div>

精密科學

雅培

<p>雅培已同意以 210 億美元收購精密科學，向股東支付每股 105 美元。精密科學以其癌症篩查測試如 Cologuard 而聞名，預計今年將產生約 30 億美元的收入。這項收購是製藥公司在癌症篩查開發方面大量投資的更廣泛趨勢的一部分</p>

為什麼這家癌症篩查公司的股價在週四上漲了 17%